dobutamine has been researched along with allopurinol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Damen, J; Gimpel, JA; Hitchcock, JF; Lahpor, JR; van der Molen, AJ | 1 |
| Jacinto, SM; Jandhyala, BS | 1 |
| Belzer, FO; Lopukhin, SY; Southard, JH | 1 |
| Arakawa, H; Hirose, H; Ishikawa, M; Mori, Y; Murakawa, S; Yamada, T | 1 |
| Cheng, CP; Cheng, HJ; Igawa, A; Little, WC; Tachibana, H; Ukai, T; Zhang, ZS | 1 |
1 review(s) available for dobutamine and allopurinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for dobutamine and allopurinol
| Article | Year |
|---|---|
Reduction of reperfusion injury of human myocardium by allopurinol: a clinical study.
Topics: Adenosine Triphosphate; Allopurinol; Birefringence; Calcium; Coronary Artery Bypass; Dobutamine; Dopamine; Female; Humans; Leukotriene B4; Leukotriene C4; Male; Middle Aged; Myocardial Reperfusion Injury; Postoperative Period | 1995 |
11 other study(ies) available for dobutamine and allopurinol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Salutary effects of dopexamine, a DA-1 and beta-2 agonist, on free radical-induced toxicity in anesthetized rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic beta-Agonists; Animals; Blood Pressure; Dobutamine; Dopamine; Fenoldopam; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine; Superoxide Dismutase; Xanthine; Xanthine Oxidase; Xanthines | 1994 |
University of Wisconsin solution containing 2,3-butanedione-monoxime extends myocardium preservation time.
Topics: Adenosine; Allopurinol; Animals; Cardiac Output; Diacetyl; Dobutamine; Glutathione; Heart; Insulin; Myocardial Reperfusion; Organ Preservation; Organ Preservation Solutions; Rabbits; Raffinose | 1993 |
Simple cold storage of the heart with the University of Wisconsin solution: evaluation in canine heterotopically and orthotopically transplanted heart.
Topics: Adenosine; Allopurinol; Animals; Dobutamine; Dogs; Glutathione; Heart Arrest; Heart Transplantation; Insulin; Organ Preservation; Organ Preservation Solutions; Raffinose; Reperfusion; Solutions; Stroke Volume; Time Factors; Transplantation, Heterotopic | 1993 |
Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure.
Topics: Allopurinol; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dogs; Drug Interactions; Free Radical Scavengers; Heart Diseases; Heart Rate; Myocardial Contraction; Physical Conditioning, Animal | 2001 |